血浆衍生治疗市场- 副产品（免疫球蛋白、凝血因子、白蛋白）、应用（血友病、原发性免疫缺陷病、特发性/免疫性血小板减少性紫斑症(ITP)）、全球预测，2023 -2032 年

由于血浆采集中心和製造设施网络不断扩大，2023 年至 2032 年间，全球血浆衍生治疗市场将以 7.5% 的CAGR成长。这些基础设施的不断增长满足了对血浆衍生疗法不断增长的需求。随着血浆可及性的增加，市场上治疗产品的生产不断增加，确保了更稳健的供应链。此次扩张将在满足全球对血浆衍生疗法不断增长的需求方面发挥关键作用，并将为市场的整体发展做出重大贡献。

例如，2023 年，日本生物製药公司武田製药 (Takeda Pharmaceutical) 正在大阪建造日本最大的最先进设施，用于生产血浆衍生疗法 (PDT)。这项策略性倡议增强了武田的製造和供应能力，满足全球对 PDT 不断增长的需求，并满足日本及其他地区不断增长的患者需求。此举标誌着武田为加强血浆衍生治疗市场、增强生产能力以满足全球需求以及满足日益增长的患者需求做出了重大贡献。

血浆衍生治疗产业根据产品、应用和地区而分散。

受白蛋白在各种医疗干预措施中的多功能应用和重要作用的推动，白蛋白细分市场将在 2032 年建立重要的市场立足点。作为一种重要的血浆蛋白，具有广泛的治疗用途，包括重症监护、手术和创伤，白蛋白将因其不可或缺的价值而脱颖而出。随着对白蛋白疗法的需求不断增长，该细分市场将在塑造血浆衍生疗法行业前景方面发挥关键作用。

血浆衍生疗法的特发性/免疫性血小板减少性紫斑症 (ITP) 市场规模将在 2032 年大幅增长，这归因于 ITP 发病率的不断上升以及人们日益认识到血浆衍生疗法作为有效干预措施。随着人们越来越关註解决自体免疫疾病，特别是 ITP，对有针对性和可靠的治疗方法的需求正在上升。医学研究和治疗创新的不断进步将进一步将 ITP 领域定位为血浆衍生疗法不断扩大的领域的关键贡献者，满足关键的医疗保健需求。

由于其先进的医疗基础设施和强大的研发工作，欧洲将在 2023 年和 2032 年实现显着的CAGR。血浆相关疾病盛行率的上升加剧了这一趋势。欧洲的医疗保健格局以技术进步和对医疗创新的承诺为标誌，凸显了其在塑造血浆衍生治疗行业发展轨迹方面的关键作用，使其成为该行业增长和发展的主要贡献者。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：血浆衍生疗法市场洞察

• 行业细分
• 产业格局
• 产业影响力
  • 成长动力
    • 罕见病患疾病率不断上升
    • 对治疗遗传性疾病的先进疗法的需求不断增长
    • 全球血浆采集中心数量增加
    • 全国越来越多地采用免疫球蛋白
  • 产业陷阱与挑战
    • 严格的监理政策
• 成长潜力分析
• COVID-19 影响分析
• 监管环境
  • 我们
  • 欧洲
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪錶板

第 5 章：血浆衍生疗法市场估计和预测：按产品分类，2018-2032 年

• 主要动向：按产品
• 免疫球蛋白
• 凝血因子
• 白蛋白
• 其他产品

第 6 章：血浆衍生治疗市场估计与预测：按应用，2018-2032

• 主要动向：按应用
• 血友病
• 原发性免疫缺乏疾病
• 特发性/免疫性血小板减少性紫斑症 (ITP)
• 其他应用

第 7 章：血浆衍生治疗市场估计与预测：按地区，2018 - 2032

• 主要动向：按地区
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 8 章：公司简介

• CSL Behring
• Takeda Pharmaceutical Company Limited.
• Biotest AG
• Octapharma
• BPL
• ADMA Biologics
• Grifols, SA
• Kedrion
• Kamada Pharmaceuticals.
• SK Plasma
• Pfizer, Inc.

Global Plasma Derived Therapy Market will grow at a 7.5% CAGR between 2023 and 2032, owing to the expanding network of plasma collection centers and manufacturing facilities. The continuous growth of these infrastructure elements addresses the escalating demand for plasma-derived therapies. With increased accessibility to plasma, the market experiences a boost in the production of therapeutic products, ensuring a more robust supply chain. This expansion will play a pivotal role in meeting the growing global demand for plasma-derived therapies and will significantly contribute to the market's overall development.

For instance, in 2023, Takeda Pharmaceutical, a Japanese biopharmaceutical company, is constructing a state-of-the-art facility in Osaka, the largest of its kind in Japan, to manufacture plasma-derived therapies (PDTs). This strategic initiative enhances Takeda's manufacturing and supply capabilities, meeting the growing global demand for PDTs and addressing increased patient needs in Japan and beyond. This move marks Takeda's significant contribution to strengthening the plasma-derived therapy market, augmenting production capabilities to meet global demand, and addressing increasing patient needs.

The plasma derived therapy industry is fragmented based on product, application, and region.

The albumin segment will establish a significant market foothold by 2032, fueled by the versatile applications and essential role of albumin in various medical interventions. As a crucial plasma protein with widespread therapeutic uses, including in critical care, surgery, and trauma, albumin will stand out for its indispensable value. With a rising demand for albumin-based therapies, this segment will play a pivotal role in shaping the plasma derived therapy industry outlook.

The plasma derived therapy market size idiopathic/immune thrombocytopenic purpura (ITP) segment will witness substantial growth through 2032, attributed to the escalating incidence of ITP and the growing recognition of plasma-derived therapies as effective interventions. With an increasing focus on addressing autoimmune disorders, particularly ITP, the demand for targeted and reliable therapies is rising. Ongoing advancements in medical research and therapeutic innovation will further position the ITP segment as a key contributor to the expanding landscape of plasma-derived therapies, addressing critical healthcare needs.

Europe will register a notable CAGR during 2023 and 2032 due to its advanced healthcare infrastructure and robust research and development efforts. The rising prevalence of plasma-related disorders adds momentum to this trend. Europe's healthcare landscape, marked by technological advancements and a commitment to medical innovation, underscores its pivotal role in shaping the trajectory of the plasma derived therapy industry, making it a primary contributor to the industry growth and development.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.1 Covid-19 impact analysis at global level
• 1.2 Data validation
• 1.3 Data sources
  • 1.3.1 Primary
  • 1.3.2 Secondary
    • 1.3.2.1 Paid sources
    • 1.3.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Plasma derived therapy industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Product trends
  • 2.1.3 Application trends
  • 2.1.4 Regional trends

Chapter 3 Plasma Derived Therapy Market Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032 (USD Million)
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Increasing prevalence of rare diseases
    • 3.3.1.2 Growing demand for advanced therapeutic for treatment of genetic disorders
    • 3.3.1.3 Increase in number of plasma collection centers across the globe
    • 3.3.1.4 Rising adoption of immunoglobulins across the nation
  • 3.3.2 Industry pitfalls and challenges
    • 3.3.2.1 Stringent regulatory policies
• 3.4 Growth potential analysis
  • 3.4.1 By product
  • 3.4.2 By application
• 3.5 COVID-19 impact analysis
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Plasma Derived Therapy Market Estimates and Forecast, By Product, 2018-2032 (USD Million)

• 5.1 Key trends, by product
• 5.2 Immunoglobulins
• 5.3 Coagulation factors
• 5.4 Albumin
• 5.5 Other products

Chapter 6 Plasma Derived Therapy Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

• 6.1 Key trends, by application
• 6.2 Hemophilia
• 6.3 Primary immunodeficiency diseases
• 6.4 Idiopathic/Immune thrombocytopenic purpura (ITP)
• 6.5 Other applications

Chapter 7 Plasma Derived Therapy Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

• 7.1 Key trends, by region
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 Rest of Asia Pacific
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
  • 7.5.4 Rest of Latin America
• 7.6 Middle East & Africa
  • 7.6.1 South Africa
  • 7.6.2 Saudi Arabia
  • 7.6.3 UAE
  • 7.6.4 Rest of Middle East & Africa

Chapter 8 Company Profiles

• 8.1 CSL Behring
• 8.2 Takeda Pharmaceutical Company Limited.
• 8.3 Biotest AG
• 8.4 Octapharma
• 8.5 BPL
• 8.6 ADMA Biologics
• 8.7 Grifols, SA
• 8.8 Kedrion
• 8.9 Kamada Pharmaceuticals.
• 8.10 SK Plasma
• 8.11 Pfizer, Inc.

Data Tables

• TABLE 1. Market revenue, by product (2022)
• TABLE 2. Market revenue, by application (2022)
• TABLE 3. Market share, by region (2022)
• TABLE 4. Global plasma derived therapy market, 2018 - 2022 (USD Million)
• TABLE 5. Global plasma derived therapy market, 2023 - 2032 (USD Million)
• TABLE 6. Global plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 7. Global plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 8. Global plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 9. Global plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 10. Global plasma derived therapy market, by region, 2018 - 2022 (USD Million)
• TABLE 11. Global plasma derived therapy market, by region, 2023 - 2032 (USD Million)
• TABLE 12. Industry impact forces
• TABLE 13. Coagulation factors market size, by region, 2018 - 2022 (USD Million)
• TABLE 14. Coagulation factors market size, by region, 2023 - 2032 (USD Million)
• TABLE 15. Immunoglobulins market size, by region, 2018 - 2022 (USD Million)
• TABLE 16. Immunoglobulins market size, by region, 2023 - 2032 (USD Million)
• TABLE 17. Albumin market size, by region, 2018 - 2022 (USD Million)
• TABLE 18. Albumin market size, by region, 2023 - 2032 (USD Million)
• TABLE 19. Other products market size, by region, 2018 - 2022 (USD Million)
• TABLE 20. Other products market size, by region, 2023 - 2032 (USD Million)
• TABLE 21. Primary immunodeficiency diseases market size, by region, 2018 - 2022 (USD Million)
• TABLE 22. Primary immunodeficiency diseases market size, by region, 2023 - 2032 (USD Million)
• TABLE 23. Hemophilia market size, by region, 2018 - 2022 (USD Million)
• TABLE 24. Hemophilia market size, by region, 2023 - 2032 (USD Million)
• TABLE 25. Idiopathic thrombocytopenic purpura (ITP) market size, by region, 2018 - 2022 (USD Million)
• TABLE 26. Idiopathic thrombocytopenic purpura (ITP) market size, by region, 2023 - 2032 (USD Million)
• TABLE 27. Other applications market size, by region, 2018 - 2022 (USD Million)
• TABLE 28. Other applications market size, by region, 2023 - 2032 (USD Million)
• TABLE 29. North America market, by country, 2018 - 2022(USD Million)
• TABLE 30. North America market, by country, 2023 - 2032 (USD Million)
• TABLE 31. North America plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 32. North America plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 33. North America plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 34. North America plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 35. U.S. plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 36. U.S. plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 37. U.S. plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 38. U.S. plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 39. Canada plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 40. Canada plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 41. Canada plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 42. Canada plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 43. Europe market, by country, 2018 - 2022(USD Million)
• TABLE 44. Europe market, by country, 2023 - 2032 (USD Million)
• TABLE 45. Europe plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 46. Europe plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 47. Europe plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 48. Europe plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 49. Germany plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 50. Germany plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 51. Germany plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 52. Germany plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 53. UK plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 54. UK plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 55. UK plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 56. UK plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 57. France plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 58. France plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 59. France plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 60. France plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 61. Italy plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 62. Italy plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 63. Italy plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 64. Italy plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 65. Spain plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 66. Spain plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 67. Spain plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 68. Spain plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 69. Rest of Europe plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 70. Rest of Europe plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 71. Rest of Europe plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 72. Rest of Europe plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 73. Asia Pacific market size, by country, 2018 - 2022(USD Million)
• TABLE 74. Asia Pacific market size, by country, 2023 - 2032 (USD Million)
• TABLE 75. Asia Pacific plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 76. Asia Pacific plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 77. Asia Pacific plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 78. Asia Pacific plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 79. Japan plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 80. Japan plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 81. Japan plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 82. Japan plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 83. China plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 84. China plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 85. China plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 86. China plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 87. India plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 88. India plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 89. India plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 90. India plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 91. Australia plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 92. Australia plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 93. Australia plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 94. Australia plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 95. Rest of Asia Pacific plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 96. Rest of Asia Pacific plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 97. Rest of Asia Pacific plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 98. Rest of Asia Pacific plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 99. Latin America market size, by country, 2018 - 2022(USD Million)
• TABLE 100. Latin America market size, by country, 2023 - 2032 (USD Million)
• TABLE 101. Latin America plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 102. Latin America plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 103. Latin America plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 104. Latin America plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 105. Brazil plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 106. Brazil plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 107. Brazil plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 108. Brazil plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 109. Mexico plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 110. Mexico plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 111. Mexico plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 112. Mexico plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 113. Argentina plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 114. Argentina plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 115. Argentina plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 116. Argentina plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 117. Rest of Latin America plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 118. Rest of Latin America plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 119. Rest of Latin America plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 120. Rest of Latin America plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 121. Middle East & Africa market size, by country, 2018 - 2022(USD Million)
• TABLE 122. Middle East & Africa market size, by country, 2023 - 2032 (USD Million)
• TABLE 123. Middle East & Africa plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 124. Middle East & Africa plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 125. Middle East & Africa plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 126. Middle East & Africa plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 127. South Africa plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 128. South Africa plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 129. South Africa plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 130. South Africa plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 131. Saudi Arabia plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 132. Saudi Arabia plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 133. Saudi Arabia plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 134. Saudi Arabia plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 135. UAE plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 136. UAE plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 137. UAE plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 138. UAE plasma derived therapy market, by application, 2023 - 2032 (USD Million)
• TABLE 139. Rest of Middle East & Africa plasma derived therapy market, by product, 2018 - 2022(USD Million)
• TABLE 140. Rest of Middle East & Africa plasma derived therapy market, by product, 2023 - 2032 (USD Million)
• TABLE 141. Rest of Middle East & Africa plasma derived therapy market, by application, 2018 - 2022(USD Million)
• TABLE 142. Rest of Middle East & Africa plasma derived therapy market, by application, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Plasma derived therapy industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by product
• FIG 8 Growth potential analysis, by application
• FIG 9 Porter's analysis
• FIG 10 PESTEL analysis
• FIG 11 Company matrix analysis, 2022
• FIG 12 Competitive analysis of major market players, 2022
• FIG 13 Competitive positioning matrix, 2022
• FIG 14 Strategic dashboard, 2022